Resuscitation Devices Market Size, Share & Industry Analysis, By Product (Airway Management Devices [Infraglottic Devices, Supraglottic Devices, Laryngoscopes, and Others], Emergency Care Ventilators, and Defibrillators), By End-user (Hospitals & ASCs, Homecare, and Others), and Regional Forecast, 2024-2032

The global resuscitation devices market size was valued at USD 4.78 billion in 2023. The market is projected to grow from USD 5.06 billion in 2024 to USD 9.00 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period. North American dominated the resuscitation devices market with a market share of 51.05% in 2023.

Resuscitation devices such as automated external defibrillators and manual resuscitators, are used to ventilate the lungs to initiate the breathing of an unconscious person. The increasing prevalence of obstructive pulmonary disease and cardiovascular diseases and the increasing number of road accidents have been fueling the demand for these devices globally.

• For instance, as per the data published by the Ministry of Road Transports and Highway, in 2022, around 1,130 road accidents and 422 deaths occurred daily in India.


• Moreover, as per the data published by the World Health Organization (WHO), in 2023, globally, around 92.0% of fatalities occurred on the road. Additionally, road traffic accidents are the leading cause of death in children and young adults aged 5-29 years.

Furthermore, the increasing focus of market players on new product launches and rising awareness among the population regarding the above-mentioned emergency cases has also been fueling the global resuscitation devices market growth. 

The global resuscitation devices market experienced a decline during the COVID-19 outbreak in 2020 due to the reduced number of accidents, emergency cases requiring resuscitation, and hospital admissions. However, the market experienced significant growth in 2021 and 2022 due to the increase in the number of hospital visits.

Resuscitation Devices Market Trends

Increasing Focus of Market Players on New Product Launches

The prevalence of cardiovascular diseases, and pulmonary diseases has been increasing significantly. Moreover, the cases of respiratory diseases in newborns and emergency medical cases requiring resuscitation devices have been increasing significantly worldwide.

Such an increasing burden of cardiac arrest and respiratory problems has been increasing the demand for these devices globally. In order to fuel this increasing demand, market players have increased their focus on new product launches.

• For instance, in October 2021, Movair, a respiratory therapy company, announced the launch of Luisa, a technologically advanced ventilator that can be used for hospital and portable applications. These products can be used for invasive and non-invasive purposes.


• Similarly, in 2020, Nihon Kohden Corporation launched the NK AWS-S200 video laryngoscope to provide critical care to patients suffering from COVID-19 or respiratory diseases, even in difficult situations.

Moreover, market players have also been focusing on expanding their product availability across the globe. For instance, in August 2023, Medline, a medical device manufacturer and distributor, partnered with Flight Medical, an Israeli-based medical device company, to distribute the Flight 60 ventilator through Medline. 

Resuscitation Devices Market Growth Factors

Increasing Prevalence of Diseases such as Pulmonary Diseases and Cardiac Arrest has been Fueling the Market Growth

The prevalence of cardiovascular diseases, chronic obstructive pulmonary disease (COPD), cardiac arrest, and other pulmonary diseases is increasing at a significant rate across the globe.

• For instance, as per the data published by the Centers for Disease Control and Prevention (CDC), in 2023, around 1 in every adult aged 20 and above have coronary artery disease (CAD).


• Moreover, as per the same source, around 805,000 individuals suffer from heart attacks annually in the U.S. Out of this number, around 605,000 people suffer from heart attacks for the first time.

Similarly, the prevalence of chronic obstructive pulmonary disease (COPD) has also been increasing at a significant rate worldwide. For instance, as per the data published by BioMed Central Ltd in 2022, the prevalence of COPD was 8.9% among the general population aged 35 and older in Latin America and the Caribbean. As per the same research study, the prevalence of COPD among men was 13.7%, whereas in women it was 6.7%.

Such a rising burden of these diseases has been increasing the demand for emergency care and hospital admissions. For instance, as per the report published by the Centers for Disease Control and Prevention (CDC) in 2021, there were around 139.8 million total emergency department visits in the U.S. Out of this number, around 75.6 million individuals were female, and 64.2 million were male.

The prevalence of the above-mentioned chronic diseases and the increasing number of emergency care visits have been increasing the demand for resuscitation devices for emergency treatment and providing critical care in ambulances.

Furthermore, the increasing proportion of premature births has also fueled the demand for these devices. For instance, as per the data published by the World Health Organization (WHO), in 2020, there were around 13.4 million preterm births globally. This number ranged between 4.0 and 16.0% in 2020 across countries.

The rising prevalence of chronic obstructive pulmonary disease (COPD), cardiac arrest, and the high incidence of preterm births has been fueling the demand for resuscitation devices, thereby fueling the market growth.

RESTRAINING FACTORS

Complications Associated with the Use of Airway Management Devices have been Negatively Impacting the Market 

The increasing prevalence of respiratory disorders and cardiac arrest has been fueling the demand for resuscitation devices. However, certain limitations are associated with using airway management devices, which have been hampering the market growth.

• For instance, as per the data published by the Crown in 2019, tracheostomy is considered a safe medical procedure. However, it may cause early complications such as collapsed lungs, bleeding, and infection. Moreover, complications can be faced in the long-term use of these products, such as a failure in the healing of tracheostomy wounds, collapsed windpipe, and narrowed windpipe.

Moreover, other airway management devices, such as laryngeal masks, can also cause certain complications in pediatric patients, including airway restriction, vomiting, stridor, and soft tissue trauma.

• For instance, as per the research study published by Springer Nature through its journal Cureus in 2022, out of the total studied pediatric patients, around 6.6% of the patients suffered from laryngospasm. Meanwhile, 20% of them suffered from airway obstruction, 15% of the patients suffered from cough, and 10% of the patients suffered from peripheral oxygen desaturation.

Such complications associated with the use of these airway management devices have been limiting their adoption among the population, thereby hindering market growth.

Resuscitation Devices Market Segmentation Analysis

By Product Analysis

Airway Management Devices Dominated due to Increasing Prevalence of COPD

On the basis of product, the market is segmented into airway management devices, emergency care ventilators, and defibrillators.

The airway management devices are further sub-segmented into infraglottic devices, supraglottic devices, laryngoscopes, and others. The airway management devices segment dominated the market in 2023. The dominance of the segment is attributed to the rising prevalence of chronic obstructive pulmonary diseases (COPD) and increasing demand for these devices.

• For instance, in February 2020, Smith Medical, now a part of ICU Medical, launched Polyvinyl Chloride (PVC) tracheostomy tube and expanded its tracheostomy product portfolio.

Moreover, the ventilators segment is expected to grow at a significant CAGR during the forecast period. The growth of the segment is attributed to the increasing number of emergency care visits and the increasing number of new product launches.

• In July 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd launched SV300 Pro, a turbine-based ventilator. The device consists of advanced technology that helps to address difficult challenges.

By End-user Analysis

Hospitals & ASCs Segment Dominated due to High Volume of Emergency Department Visits

Based on end-user, the market is segmented into hospitals & ASCs, homecare, and others.

The hospitals & ASCs segment dominated the market in 2023. The dominance of the segment is attributed to the increasing number of emergency department visits.

• For instance, as per the data published by BioMed Central Ltd, in 2021, around 446,484 emergency department admissions were recorded in a hospital in Singapore in a time span of 10 years.

Moreover, the homecare segment is expected to grow at a significant CAGR during the forecast period. The growth of the segment is attributed to the increasing cases of sudden cardiac arrest, rising geriatric population, and rising awareness regarding emergency resuscitation devices.

REGIONAL INSIGHTS

By geography, the market is studied across Europe, North America, the Asia Pacific, Latin America, and the Middle East & Africa.

North America dominated the global market in 2023 by accounting for major market share of USD 2.44 billion. The increasing number of cases of sudden cardiac arrests in the U.S. has been creating awareness regarding these devices for the emergency first line of treatment. This factor has been fueling the market growth in the region.

• For instance, as per the data published by the Sudden Cardiac Arrest Foundation, 2021, 73.4% of out-of-hospital cardiac arrests (OHCA) occurred at residence, 16.3% occurred at public settings, and 10.3% at nursing homes.

The market in Europe accounted for a substantial market share in 2023, attributed to the strong presence of market players such as Koninklijke Philips N.V., Hamilton Medical, and Convatec Group PLC, among others.

The Asia Pacific market is anticipated to grow at a significant CAGR during the forecast period. The growth of the market in Asia Pacific is attributed to the rising prevalence of chronic obstructive pulmonary disease and cardiovascular diseases, which can lead to sudden cardiac arrests in the region. This factor has been fueling the demand for emergency resuscitation in the region.

• For instance, as per the data published by Lung India in 2021, out of the total studied population in India, the prevalence of COPD was 7.4%. Moreover, it was also observed that COPD was more common in males as compared to females, and it was higher in urban areas.

List of Key Companies in Resuscitation Devices Market

Increasing Focus of Market Players on Introducing Technologically Advanced Resuscitation Devices is Responsible for their Growth in the Market

Getinge AB, Ambu A/S, and Teleflex Incorporated are the key players that accounted for a significant portion of the global resuscitation devices market share in 2023. The growth of these players in the market is attributed to their focus on the launch of technologically advanced resuscitation devices.

• For instance, in March 2023, Ambu A/S relaunched the second generation of its VivaSightTM 2 DLT for monitoring patients during one-lung ventilation procedures.

Moreover, other players in the market, such as Koninklijke Philips N.V., Hamilton Medical, and Getinge AB, among others, have been focusing on the expansion of their production capacity to fuel their revenue growth.

• For instance, in April 2020, Koninklijke Philips N.V. and the U.S. government collaborated to expand ventilator production capacity to fight against the COVID-19 pandemic.

LIST OF KEY COMPANIES PROFILED:

• Koninklijke Philips N.V. (Netherlands)


• Hamilton Medical (Switzerland)


• Getinge AB (Sweden)


• Medtronic (Ireland)


• Teleflex Incorporated (U.S.)


• Convatec Group PLC (U.K.)


• Ambu A/S (Denmark)


• Flexicare Medical Limited (U.K.)


• ICU Medical (U.S.)


• ZOLL Medical Corporation (Asahi Kasei) (U.S.)


• Stryker (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• July 2023 – Ambu A/S announced that its product VivaSigh 2 SLT, a lung ventilation device, is ready for European commercialization.


• March 2022 – ZOLL Medical Corporation (Asahi Kasei) launched Arrhythmia Management System (AMS). The product adds biometric data, such as heart rate, and respiratory rate, to the ECG information given by traditional MCT devices.


• May 2021 – Medtronic commercialized the SonarMed airway monitoring system in the U.S. This expanded the company's product portfolio for airway management devices.


• May 2020 – Hamilton Medical partnered with Raumedic, a pharmaceutical and medical device solution provider, to expand the production of ventilators.


• April 2020 – Koninklijke Philips N.V. announced plans to increase the production of ICU ventilators to fulfill the increasing demand for ventilators during the pandemic.

REPORT COVERAGE

The global resuscitation devices market report provides a detailed competitive landscape. It also includes key insights, such as top industry developments covering partnerships, mergers, and acquisitions. Additionally, it focuses on key points, such as new product launches in the market. Furthermore, the report covers regional analysis of different segments, profiles of key market players, market trends, and the impact of COVID-19 on the market. The report consists of quantitative and qualitative insights that have contributed to the market's growth.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 7.5% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Product Airway Management Devices Infraglottic Devices Supraglottic Devices Laryngoscopes Others Emergency Care Ventilators Defibrillators
By End-user Hospitals & ASCs Homecare Others
By Region North America (by Product, by End-user, and by Country) U.S. Canada Europe (by Product, by End-user, and by Country/Sub-region) U.K. Germany France Spain Italy Scandinavia Rest of Europe Asia Pacific (by Product, by End-user, and by Country/Sub-region) Japan China Australia India Southeast Asia Rest of Asia Pacific Latin America (by Product, by End-user, and by Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (by Product, by End-user, and by Country/Sub-region) South Africa GCC Rest of Middle East & Africa